Evidence map›Paper›PMID 41077653›Full record

ReviewHeart failure clinics2025

Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy.

Jamey Cutts, Christopher Kramer

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart failure clinics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jamey CuttsDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Christopher KramerCardiovascular Division, UVA Health, Box 800158, 1215 Lee Street, Charlottesville, VA 22908, USA. Electronic address: CMK2N@uvahealth.org.

Funding

Training in Cardiovascular Imaging ResearchT32EB003841 · NIBIB · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jonathan R Lindner · 2004 to 2026
$4.4M
NIBIB NIH HHS T32 EB003841
6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by pathologic hypertrophy in the absence of a potentially causative disease process and carries increased risk of heart failure, atrial fibrillation, and sudden cardiac death. Synergistic use of multi-modal imaging is pivotal and necessary in the diagnosis and management of patients with, or at risk for, HCM. Echocardiography, cardiac MR, and cardiac computed tomography each have important roles and limitations in assessing the morphologic changes responsible for symptoms and morbidity in HCM. In this article, we will explore these modalities and their roles in evaluating HCM.

Indexed as

Cardiomyopathy, HypertrophicMultimodal ImagingEchocardiographyHumansMagnetic Resonance ImagingMagnetic Resonance Imaging, CineTomography, X-Ray ComputedCardiac computed tomographyCardiac MRIEchocardiogramHypertrophic cardiomyopathyMulti-modality imaging

Identifiers

PMID41077653
PMCPMC13456298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.